← Product Code [KWD](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWD) · K023770 # K2 HEMI TOE IMPLANT SYSTEM (FORMERLY ZOBEL GREAT TOE IMPLANT SYSTEM) (K023770) _Kinetikos Medical, Inc. · KWD · Dec 12, 2002 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWD/K023770 ## Device Facts - **Applicant:** Kinetikos Medical, Inc. - **Product Code:** [KWD](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWD.md) - **Decision Date:** Dec 12, 2002 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 888.3730 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The Great Toe Implant System is indicated for use in the treatment of patients with inflammatory arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head, along with the following clinical conditions; Hallux valgus, hallux rigidus and an unstable or painful Metatarsal / phalangeal (MTP) ioint. ## Device Story K2 Hemi Toe Implant System is a polymer prosthesis for the first metatarsal joint; used for treatment of inflammatory arthritis, hallux valgus, hallux rigidus, and unstable/painful MTP joints. Device consists of 4 sizes of implants; designed for press-fit application by surgeons. Modification includes addition of titanium plasma coating to implant surface and removal of spike features. Device functions as a hemi-arthroplasty component to replace the joint surface; intended to restore joint function and reduce pain in patients with sufficient bone stock. Surgical protocol remains identical to predicate systems. ## Clinical Evidence No clinical data provided; substantial equivalence is based on design, material, and technological similarities to predicate devices. ## Technological Characteristics Polymer prosthesis for hemi-toe arthroplasty; features titanium plasma coating. Designed for press-fit fixation. Available in 4 sizes. Sterilization and packaging processes are identical to predicate devices. ## Regulatory Identification A toe joint phalangeal (hemi-toe) polymer prosthesis is a device made of silicone elastomer intended to be implanted to replace the base of the proximal phalanx of the toe. ## Predicate Devices - Harmos Orthodpedic, Inc., Great Toe Implant System ([K014164](/device/K014164.md)) - Futura Biomedical Hemi Toe implant ([K971047](/device/K971047.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # Special 510(k) Notification ADMINISTRATIVE INFORMATION Manufacturer Name: Kinetikos Medical, Inc. 4115 Sorrento Valley Blvd. San Diego, CA 92121 Telephone (858) 558 2233 FAX (858) 558 0838 John Spampinato Official Contact Representative John Spampinato, Quality Assurance Manager Kinetikos Medical, Inc. 4115 Sorrento Valley Blvd. San Diego, CA 92121 Telephone (858) 558 2233 # 406 FAX (858) 558 0838 #### DEVICE NAME | Classification Name: | Toe joint, phalangeal, (hemi toe) polymer prosthesis
888.3730 | |-------------------------|------------------------------------------------------------------| | Trade/Proprietary Name: | K2 Hemi Toe Implant System | | Common Name: | Great Toe Prosthesis | ## PREDICATE DEVICE INFORMATION The principal predicate devices for this modification is the Harmos Orthodpedic, Inc., Great Toe Implant System - originally cleared by FDA on March 12, 2002 under K014164, and the Futura Biomedical Hemi Toe implant cleared by FDA on June 20, 1997 under K971047, referenced in this submission owing to its titanium plasma coating, the removal of the spike features and various dimensional changes on the K2 Great Toe Implant. ## PACKAGING/LABELING/PRODUCT INFORMATION Packaging and labeling of the device will be the same as that of the predicate Great Toe Implant. The device will continue to be indicated for press-fit use only. Samples of a package label, product brochure and the surgical technique manual with draft changes in product illustrations, are shown in Exhibit II. P. 1/2 {1}------------------------------------------------ KOL3770 P. 2/2 # Special 510(k) Notification - Modification to the Great Toe Implant System - Page 2 #### INTENDED USE The Great Toe Implant System is indicated for use in the treatment of patients with inflammatory arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head, along with the following clinical conditions; Hallux valgus, hallux rigidus and an unstable or painful Metatarsal / phalangeal (MTP) ioint. #### SYSTEM DESCRIPTION The KMI Great Toe Implant System consists of 4 (four) sizes of toe implants. The implants will now be plasma coated. It is constructed of materials that have a lona clinical history of proven acceptance and performance. This system is intended for press fit use only and will be promoted as such in the Surgical Protocol 81-0065. Engineering drawings of the implant is shown in Exhibit III. #### EQIVALENCE TO MARKETED PRODUCT The K2 Great Toe implant has the following similarities to the predicate Great Toe implants which previously received 510/k) concurrence: - -identical design (with the exception of the elimination of the spike features) - -identical operating principle / surgical protocol - -is packaged and sterilized using identical materials and processes The primary distinct difference is the addition of a titanium plasma coating identical to coatings used in cleared, competitive products. In summary, the extra small K2 Hemi Toe Implant System described in this submission is, in our opinion, substantially equivalent to the predicate device. {2}------------------------------------------------ # DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three horizontal lines above it, representing the agency's mission to protect the health of all Americans and provide essential human services. #### Public Health Service Food and Drug Administratio 200 Corporate Boulevard Rockville MD 20850 DEC 1 2 2002 Mr. John Spampinato Ouality Assurance Manager Kinetikos Medical, Inc. 4115 Sorrento Valley Boulevard · San Diego, California 92121 Re: K023770 Trade/Device Name: K2 Hemi Great Toe Implant System Regulation Number: 21 CFR 888.3730 Regulation Name: Toe joint, phalangeal (hemi-toe), polymer prosthesis Regulatory Class: Class II Product Code: KWD Dated: November 8, 2002 Received: November 12, 2002 Dear Mr. Spampinato: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050, {3}------------------------------------------------ Page 2 – Mr. John Spampinato This letter will allow you to begin marketing your device as described in your Section 510(k premarket notification: The FDA finding of substantial equivalence of your device to a legally. marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Mark N Millman Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Special 510(k) Notification - Modification to the Great Toe Implant System Device Name: K2 Hemi Great Toe Implant System Indications for Use: The K2 Hemi Great Toe Implant System is indicated for use in the treatment of patients with inflammatory arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head, along with the following clinical conditions; Hallux valgus, hallux rigidus and an unstable or painful MTP joint. (PLEASE DO NOT WRITE BELOW THIS LINE – CONITNUE ON ANOTHER PAGE IF NECESSARY) Concurrence of CDRH, Office of Device Evaluation (ODE) OR Prescription Use_ Over-the-Counter Use 4 Mark N Milken (Division Sign-Off) Division of General Restorative Division of General, Restorative and Neurological Devices 510(k) Number K023770 --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWD/K023770](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWD/K023770) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com